Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis

Journal of Neuroinflammation

Volumn 3, Issue , 2006, Pages

  Canova, Cecile ^a   Neal, Jim W ^a   Gasque, Philippe ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b University of La Reunion   (Reunion)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CELL MARKER; COMPLEMENT COMPONENT C3B RECEPTOR; DECAY ACCELERATING FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE COFACTOR PROTEIN; MONOCLONAL ANTIBODY; PROTEIN S 100; PROTEIN ZO1; UVOMORULIN;

ADULT; AGED; ANTIGEN EXPRESSION; APICAL MEMBRANE; ARTICLE; BACTERIAL MENINGITIS; BRAIN CELL; BRAIN TISSUE; CASE REPORT; CELL LINE; CHOROID PLEXUS; CONTROLLED STUDY; EPENDYMA CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MALE; TISSUE SECTION;

EID: 33749046766     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-3-22     Document Type: Article

References (42)

1. Morgan BP: The complement system: an overview. Methods Mol Biol 2000, 150:1-13.
2. Morgan BP, Gasque P, Singhrao S, Piddlesden SJ: The role of complement in disorders of the nervous system. Immunopharmacology 1997, 38(1-2):43-50.
3. Medicus RG, Gotze O, Muller-Eberhard HJ: Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med 1976, 144(4):1076-1093.
4. Taylor P, Botto M, Walport M: The complement system. Curr Biol 1998, 8(8):R259-61.
5. Morgan BP, Gasque P: Expression of complement in the brain: role in health and disease. Immunol Today 1996, 17(10):461-466.
6. Zajicek J, Wing M, Skepper J, Compston A: Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Lab Invest 1995, 73(1):128-138.
7. Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am J Pathol 2000, 157(3):905-918.
8. Chen S, Caragine T, Cheung NK, Tomlinson S: Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones. Am J Pathol 2000, 156(3):1085-1091.
9. Adred AR, Brack CM, Schreiber G: The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol B Biochem Mol Biol 1995, 111(1):1-15.
10. Stahel PF, Barnum SR: Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology 1997, 38(1-2):65-72.
11. Stahel PF, Frei K, Fontana A, Eugster HP, Ault BH, Barnum SR: Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis. Am J Pathol 1997, 151(4):897-904.
12. Sarnat HB: Histochemistry and immunocytochemistry of the developing ependyma and choroid plexus. Microsc Res Tech 1998, 41(1):14-28.
13. Chiasson BJ, Tropepe V, Morshead CM, van der Kooy D: Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics. J Neurosci 1999, 19(11):4462-4471.
14. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J: Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999, 96(1):25-34.
15. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A: Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97(6):703-716.
16. Williams BJ, Morlin G, Valentine N, Smith AL: Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect Immun 2001, 69(2):695-705.
17. Rasmussen JM, Brandslund I, Teisner B, Isager H, Svehag SE, Maarup L, Willumsen L, Ronne-Rasmussen JO, Permin H, Andersen PL, et al.: Screening for complement deficiencies in unselected patients with meningitis. Clin Exp Immunol 1987, 68(2):437-445.
18. Sarnat HB: Ependymal reactions to injury. A review. J Neuropathol Exp Neurol 1995, 54(1):1-15.
19. Singhrao S, Cole G, Henderson WJ, Newman GR: LR White embedding allows a multi-method approach to the analysis of brain tissue from patients with Alzheimer's disease. Histochem J 1990, 22(5):257-268.
20. Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest 1999, 79(10):1247-1259.
21. Bruni JE: Ependymal development, proliferation, and functions: a review. Micocsc Res Tech 1998, 41(1):2-13.
22. Kleihues PCWK: Pathology and genetics of tumors of the nervous system. Lyon, International Agency for Research on Cancer (IARC); 1997.
23. Moss TH: Tumours of the nervous system. An ultrastructural Atlas. London Berlin Heildelberg New York Paris Tokyo, Springer Verlag; 1986.
24. Jarvis CR, Andrew RD: Correlated electrophysiology and morphology of the ependyma in rat hypothalamus. J Neurosci 1988, 8(10):3691-3702.
25. Nassif X, Bourdoulous S, Eugene E, Couraud PO: How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 2002, 10(5):227-232.
26. Virji M: Meningococcal disease: epidemiology and pathogenesis. Trends Microbiol 1996, 4(12):466-9; discussion 469-70.
27. Pollard AJ, Galassini R, van der Voort EM, Booy R, Langford P, Nadel S, Ison C, Kroll JS, Poolman J, Levin M: Humoral immune responses to Neisseria meningitides in children. Infect Immun 1999, 67(5):2441-2451.
28. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ: Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001, 184(9):1152-1162.
29. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S: Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 2002, 168(4):1886-1894.
30. Casarsa C, De Luigi A, Pausa M, De Simoni MG, Tedesco F: Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain. Eur J Immunol 2003, 33(5):1260-1270.
31. Liu L, Kita T, Tanaka N, Kinoshita Y: The expression of tumour necrosis factor in the hypothalamus after treatment with lipopolysaccharide. Int J Exp Pathol 1996, 77(1):37-44.
32. Tarlow MJ, Jenkins R, Comis SD, Osborne MP, Stephens S, Stanley P, Crocker J: Ependymal cells of the choroid plexus express tumour necrosis factor-alpha. Neuropathol Appl Neurobiol 1993, 19(4):324-328.
33. Isaksson J, Farooque M, Holtz A, Hillered L, Olsson Y: Expression of ICAM-I and CD11b after experimental spinal cord injury in rats. J Neurotrauma 1999, 16(2):165-173.
34. Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T: Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. Lymphokine Cytokine Res 1993, 12(3):167-172.
35. Laflamme N, Rivest S: Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. Faseb J 2001, 15(1):155-163.
36. Lacroix S, Feinstein D, Rivest S: The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 1998, 8(4):625-640.
37. Gregory CD: CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol 2000, 12(1):27-34.
38. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998, 392(6675):505-509.
39. Smith GL: Virus strategies for evasion of the host response to infection. Trends Microbiol 1994, 2(3):81-88.
40. Ram S, Mackinnon FG, Gulati S, McQuillen DP, Vogel U, Frosch M, Elkins C, Guttormsen HK, Wetzler LM, Oppermann M, Pangburn MK, Rice PA: The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol 1999, 36(13-14):915-928.
41. Johansson L, Rytkonen A, Bergman P, Albiger B, Kallstrom H, Hokfelt T, Agerberth B, Cattaneo R, Jonsson AB: CD46 in meningococcal disease. Science 2003, 301(5631):373-375.
42. Martino G, Furlan R, Comi G, Adorini L: The ependymal route to the CNS: an emerging gene-therapy approach for MS. Trends Immunol 2001, 22(9):483-490.